Decision Aid
OtherThe Yorkshire Dialysis Decision Aid (YoDDA) resource in web and paper format
NCT Number: NCT01671228
The purpose of this research is to develop a patient decision aid in paper and web formats to help patients with chronic kidney disease make informed dialysis treatment decisions.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1
Hull and East Yorkshire Hospital Trust, Hull, East Yorkshire, United Kingdom
This research will develop and evaluate a paper and web resource known as a decision-aid to help patients make informed decisions about dialysis treatment. The Yorkshire Dialysis Decision Aid (YoDDA) will help patients' with chronic kidney disease make informed decisions between haemodialysis and peritoneal dialysis choices by a) re-writing dialysis information in a more meaningful way for patients, b) restructuring information to make this difficult decision more manageable, and c) using prompts to help patients imagine the choices' consequences. The research will assess the acceptability of a patient decision aid in paper and web versions to patients and their carers, and its impact on patients choices about dialysis.
The programme of research included:
A survey using qualitative methods of patients with chronic kidney disease and professionals providing predialysis services to develop the Yorkshire Dialysis Decision Aid content, and integration within usual predialysis care practices.
A before-and-after study was carried out to evaluate the acceptability of the YoDDA-booklet to patients with sustained deterioration of kidney function making dialysis decision across the Yorkshire and Humber region, UK.
An experimental study was carried out on-line to evaluate the acceptability of three versions of YoDDA-web (YoDDA; YoDDA+values tasks; YoDDA_patient videos) to people, or carers of people, with kidney disease. The study was advertised with flyers within UK renal units and notices on the National Kidney Federation's website and members' magazine.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Adult patients with chronic kidney disease and carers of people with chronic kidney diseae who are making decisions about dialysis treatments.
-
Exclusion criteria
Those not literate in English
-
The Yorkshire Dialysis Decision Aid (YoDDA) resource in web and paper format
The Yorkshire dialysis decision aid (YoDDA) plus a set of narratives provided by patients on the treatment options (home and hospital haemodialysis; continuous ambulatory and automated peritoneal dialysis
The Yorkshire Dialysis decision aid (YoDDA) plus a set of questions to help patients explore what aspects of their life important to them about this decision (values clarification)
Time frame: one and six weeks after provision information about dialysis choices
Assesses patient's perception of how useful the resource was in helping patients prepare for a consultation to talk about their health decision (Graham and O'Connor, 2010). http://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_PrepDM.pdf
Time frame: one and six weeks after the provision of information
Study specific items to assess perceived usefulness of information in helping patients understand chronic kidney disease, dialysis treatments and thinking about dialysis
Time frame: one week and six weeks after the information
Study specific measure asking patients to rank order their preferred dialysis treatment (CAPD, APD, home HD, centre HD)
University of Leeds
Other
Development of a Patient Decision Aid (PtDA) to Facilitate Renal Patients Informed Decisions About Dialysis Treatments
Acronym: YoDDA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02889575
Acute Kidney Injury, Acute Kidney Tubular Necrosis
Nantes, France
View Trial DetailsNCT06216015
Chronic Disease, Chronic Kidney Failure
View Trial DetailsNCT07545629
Chronic Disease, Chronic Kidney Disease, Stage IV (Severe)
Wuhu, Anhui, China
View Trial DetailsNCT01845402
Cardiovascular Abnormalities, Cardiovascular Diseases
Paris, France
View Trial Details